Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to Type 2 diabetes

Research output: Contribution to journalArticle

Standard

Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to Type 2 diabetes. / Doney, A S F; Fischer, B; Cecil, J E; Boylan, K; McGuigan, F E; Ralston, S H; Morris, A D; Palmer, C N A.

In: Diabetologia, Vol. 47, No. 3, 03.2004, p. 555-558.

Research output: Contribution to journalArticle

Harvard

Doney, ASF, Fischer, B, Cecil, JE, Boylan, K, McGuigan, FE, Ralston, SH, Morris, AD & Palmer, CNA 2004, 'Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to Type 2 diabetes', Diabetologia, vol. 47, no. 3, pp. 555-558. https://doi.org/10.1007/s00125-003-1323-1

APA

CBE

MLA

Vancouver

Author

Doney, A S F ; Fischer, B ; Cecil, J E ; Boylan, K ; McGuigan, F E ; Ralston, S H ; Morris, A D ; Palmer, C N A. / Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to Type 2 diabetes. In: Diabetologia. 2004 ; Vol. 47, No. 3. pp. 555-558.

RIS

TY - JOUR

T1 - Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to Type 2 diabetes

AU - Doney, A S F

AU - Fischer, B

AU - Cecil, J E

AU - Boylan, K

AU - McGuigan, F E

AU - Ralston, S H

AU - Morris, A D

AU - Palmer, C N A

PY - 2004/3

Y1 - 2004/3

N2 - AIMS/HYPOTHESIS: The Pro12Ala polymorphism of peroxisome proliferator-activated receptor (PPAR)gamma has been consistently associated with Type 2 diabetes. The rare Ala12 variant is estimated to reduce the risk of developing Type 2 diabetes by 20 percent. This variant is in linkage disequilibrium with another common variant, T1431. Both have opposing associations with body weight. We therefore examined the association of specific haplotypes marked by these two variants with susceptibility to Type 2 diabetes.METHODS: We determined the PPARG genotype of a large Scottish cohort of Type 2 diabetic patients ( n=1997) and compared allele frequencies with a cohort of local children ( n=2444) and a middle-aged, population-based cohort from Scotland ( n=1061).RESULTS: Frequency of the Ala12 allele was slightly lower in the Type 2 diabetic cohort than in the children [odds ratio (OR)=0.91, p=0.1]. In contrast, the Ala12 variant was under-represented in the Type 2 diabetic population when compared with similarly aged non-diabetic adults (OR=0.74, p=0.0006). When the Ala12 variant was on a haplotype not bearing the 1431T variant, it conferred greater protection (OR=0.66, p=0.003). However, when it was present in haplotypes containing the 1431T variant (70% of Ala12 carriers), this protection was absent (OR=0.99, p=0.94).CONCLUSIONS/INTERPRETATION: We replicated the finding that the Ala12 variant of PPARgamma affords protection from Type 2 diabetes, and suggest that this protection is modulated by additional common variation at the PPARG locus.

AB - AIMS/HYPOTHESIS: The Pro12Ala polymorphism of peroxisome proliferator-activated receptor (PPAR)gamma has been consistently associated with Type 2 diabetes. The rare Ala12 variant is estimated to reduce the risk of developing Type 2 diabetes by 20 percent. This variant is in linkage disequilibrium with another common variant, T1431. Both have opposing associations with body weight. We therefore examined the association of specific haplotypes marked by these two variants with susceptibility to Type 2 diabetes.METHODS: We determined the PPARG genotype of a large Scottish cohort of Type 2 diabetic patients ( n=1997) and compared allele frequencies with a cohort of local children ( n=2444) and a middle-aged, population-based cohort from Scotland ( n=1061).RESULTS: Frequency of the Ala12 allele was slightly lower in the Type 2 diabetic cohort than in the children [odds ratio (OR)=0.91, p=0.1]. In contrast, the Ala12 variant was under-represented in the Type 2 diabetic population when compared with similarly aged non-diabetic adults (OR=0.74, p=0.0006). When the Ala12 variant was on a haplotype not bearing the 1431T variant, it conferred greater protection (OR=0.66, p=0.003). However, when it was present in haplotypes containing the 1431T variant (70% of Ala12 carriers), this protection was absent (OR=0.99, p=0.94).CONCLUSIONS/INTERPRETATION: We replicated the finding that the Ala12 variant of PPARgamma affords protection from Type 2 diabetes, and suggest that this protection is modulated by additional common variation at the PPARG locus.

KW - Adult

KW - Amino Acid Substitution

KW - Child

KW - Diabetes Mellitus, Type 2

KW - Gene Frequency

KW - Genetic Predisposition to Disease

KW - Genetic Variation

KW - Genotype

KW - Humans

KW - Mutation, Missense

KW - PPAR gamma

KW - Polymorphism, Single Nucleotide

KW - Scotland

KW - Journal Article

KW - Research Support, Non-U.S. Gov't

U2 - 10.1007/s00125-003-1323-1

DO - 10.1007/s00125-003-1323-1

M3 - Article

VL - 47

SP - 555

EP - 558

JO - Diabetologia

JF - Diabetologia

SN - 1432-0428

IS - 3

ER -